Page last updated: 2024-09-04
centhaquine and Shock
centhaquine has been researched along with Shock in 2 studies
*Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs. [MeSH]
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Agarwal, R; Agrawal, NR; Choudhuri, R; Das, S; Dhibar, DP; Gulati, A; Haveri, S; Jain, D; Lavhale, MS; Prabhu, M; Rahate, P | 1 |
| Agarwal, A; Agrawal, NR; Ali, SKN; Bothra, AR; Choudhuri, R; Gulati, A; Gupta, A; Haque, PD; Haveri, S; Jeswani, D; Maheshwari, S; Rahate, P; Sidhu, GK; Singh, GP; Singh, S | 1 |
Trials
2 trial(s) available for centhaquine and Shock
| Article | Year |
|---|---|
Resuscitative Effect of Centhaquine (Lyfaquin
Topics: Adult; COVID-19; Female; Humans; Male; Piperazines; Prospective Studies; SARS-CoV-2; Shock | 2021 |
A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Blood Pressure; Double-Blind Method; Female; Fluid Therapy; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Organ Dysfunction Scores; Piperazines; Prospective Studies; Respiration, Artificial; Shock; Time Factors; Vasoconstrictor Agents | 2021 |